Combined ROS Sensitive Folate Receptor Targeted Micellar Formulations of Curcumin Effective Against Rheumatoid Arthritis in Rat Model
DOI: https://doi.org/10.2147/ijn.s458957
IF: 7.033
2024-05-14
International Journal of Nanomedicine
Abstract:Yuanyuan Wang, 1 Ruibo Guo, 2 Ming Zou, 1 Lingling Jiang, 1 Liang Kong, 2 Sen Zhao, 1 Xuan Zhang, 1 Wei Wang, 1 Baoli Xu 1 1 Department of Pharmacy, Affiliated Zhongshan Hospital of Dalian University, Dalian, People's Republic of China; 2 School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, People's Republic of China Correspondence: Baoli Xu, Department of Pharmacy, Affiliated Zhongshan Hospital of Dalian University, No. 6 Jiefang Street, Dalian, 116001, Liaoning, People's Republic of China, Tel +86411 6289 3215, Email Introduction: Rheumatoid arthritis (RA) is an inflammatory immune-mediated disease that involves synovitis, cartilage destruction, and even joint damage. Traditional agents used for RA therapy remain unsatisfactory because of their low efficiency and obvious adverse effects. Therefore, we here established RA microenvironment-responsive targeted micelles that can respond to the increase in reactive oxygen species (ROS) levels in the joint and improve macrophage-specific targeting of loaded drugs. Methods: We here prepared ROS-responsive folate-modified curcumin micelles (TK-FA-Cur-Ms) in which thioketal (TK) was used as a ROS-responsive linker for modifying polyethylene glycol 5000 (PEG 5000 ) on the micellar surface. When micelles were in the ROS-overexpressing inflammatory microenvironment, the PEG 5000 hydration layer was shed, and the targeting ligand FA was exposed, thereby enhancing cellular uptake by macrophages through active targeting. The targeting, ROS sensitivity and anti-inflammatory properties of the micelles were assessed in vitro. Collagen-induced arthritis (CIA) rats model was utilized to investigate the targeting, expression of serum inflammatory factors and histology change of the articular cartilage by micelles in vivo. Results: TK-FA-Cur-Ms had a particle size of 90.07 ± 3.44 nm, which decreased to 78.87 ± 2.41 nm after incubation with H 2 O 2 . The micelles exhibited in vitro targeting of RAW264.7 cells and significantly inhibited inflammatory cytokine levels. Pharmacodynamic studies have revealed that TK-FA-Cur-Ms prolonged the drug circulation and exhibited augmented cartilage-protective and anti-inflammatory effects in vivo. Conclusion: The unique ROS-responsive targeted micelles with targeting, ROS sensitivity and anti-inflammatory properties were successfully prepared and may offer an effective therapeutic strategy against RA. Keywords: rheumatoid arthritis, ROS-responsive, curcumin, folate, micelles Rheumatoid arthritis (RA) is a severe immune-mediated chronic inflammatory joint disease. It can cause cartilage and bone damage, and persistent arthritic pain, swelling, and stiffness. 1,2 RA has a global prevalence of approximately 1%, and women are at a 3- times higher risk of RA than men. 3 RA can affect the quality of a patient's life and confer a heavy economic burden on society. The drugs currently used for RA treatment primarily include nonsteroidal anti-inflammatory drugs (NSAIDs), glucocorticoids (GCs), disease-modifying antirheumatic drugs (DMARDs), biological agents, and natural agents. 4,5 These drugs can improve associated symptoms and delay RA progression but are still unable to meet patient expectations because of their poor bioavailability, high clearance rates, and nonspecificity. Therefore, more effective treatment methods for RA are urgently required. With the emergence of nanomedicine, a new approach for optimized RA treatment has evolved. This approach has demonstrated its improved efficacy compared with the drug alone. 6,7 Various nanocarriers such as liposomes, dendrimers, microemulsions, nanoparticles, and micelles have been used for RA treatment. 8–10 Anti-rheumatic drugs encapsulated in nanocarriers can passively accumulate in chronic inflammatory tissues through extravasation via the leaky vasculature and subsequent inflammatory cell-mediated sequestration (ELVIS) effect, because the interendothelial cell gaps of inflamed joints can be up to 600 nm. 11 The ELVIS effect resembles the enhanced permeability and retention (EPR) effect in solid tumors. Nanodrugs are easily recognized and engulfed by the reticuloendothelial system (RES) in the blood circulation. However, hydrophilic modifications of nanomedicine can prolong their blood circulation time. Polyethylene glycol (PEG) is the most widely used hydrophilic polymer, which prolongs circulation by reducing plasma protein adsorption. 12 The expressed or upregulated membrane receptors on macrophages can serve as specific inflammatory targets for RA therapy. 13 -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology